Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Dr. Helder Nakaya is a senior researcher at the Hospital Israelita Albert Einstein and a part-time professor at the Faculty of Pharmaceutical Sciences of the University of São Paulo (USP). Co-founder and chief scientific officer of the Brazilian startups D2DNA, Hylix, HumanIA, and the Danish startup Synamics Therapeutics. He is also an adjunct professor at Emory University in Atlanta, United States, and was vice-director of FCF-USP. Member of the Deliberative Council of the Brazilian Society of Immunology and the board of the Brazilian Association of Bioinformatics and Computational Biology. He was an affiliate member of the Brazilian Academy of Sciences (ABC), a consultant to CEPI (Coalition for Epidemic Preparedness Innovations) and IUIS (International Union of Immunological Societies), and a member of the scientific advisory board of the European Ebola Vaccine Consortium and the International Institute for Applied Systems Analysis (IIASA). Computational Systems Biology lab website: www.csbiology.org (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
(Only some records are available in English at this moment)
(Only some records are available in English at this moment)
(Only some records are available in English at this moment)
(Only some records are available in English at this moment)